Teva fast-tracks $2bn cost-cutting plan with 10% workforce reduction
Teva says 5,000 jobs will be lost next year as it accelerates its global cost reduction programme, set to save $2bn (€1.48bn) annually by 2017.
Archives for October 14, 2013
Colorcon calls on Evonik to help sell delayed-release tech
Colorcon has called on Evonik Industries to help it sell a co-developed, delayed release pill coating technology.
Pharma Action teams with Tönnies to supply 100% German heparin
Pharma Action says safety of supply will counter the low costs of Chinese made heparin as it inks a joint venture with the Tönnies Group.
Parexel strikes another eClinical deal in Asia
Parexel has teamed up with Japanese trial management services firm Fuijitsu Systems West in an agreement that underlines the CROs eClinical growth ambitions in Asia.
Aesica: New Centre to be breath of fresh air for inhalation development
Aesica says its new Lead Technical Centre will be a ‘hotbed of innovation’ providing full inhalation development and manufacturing services.
MedImmune looks to 'next generation biologics' with $200m ADC investment
AstraZeneca has become the latest company to invest in antibody-drug conjugate (ADC) technology with the acquisition of Spirogen for $200m (€148m).